Literature DB >> 22713306

Pulmonary valve implantation using self-expanding tissue valve without cardiopulmonary bypass reduces operation time and blood product use.

Qiang Chen1, Mark Turner2, Massimo Caputo3, Serban Stoica3, Stefano Marianeschi4, Andrew Parry3.   

Abstract

OBJECTIVE: The study objective was to review our initial experience with newly developed off-pump pulmonary valve implantation techniques and compare outcomes with the conventional approach.
METHODS: Thirteen symptomatic patients with severe pulmonary regurgitation underwent pulmonary valve implantation, 6 without cardiopulmonary bypass (group 1: age, 28 ± 21 years; range, 12-62; body surface area range, 1.38-2.39 m(2)) and 7 with cardiopulmonary bypass (group 2: age, 23 ± 13 years; range, 10-46; body surface area range, 1.31-1.89 m(2)). Ten patients had previous repair of tetralogy of Fallot, and 3 patients had pulmonary valvotomy/valvuloplasty.
RESULTS: Mean operation times were 166 minutes (range, 110-240) in group 1 and 299 minutes (range, 221-375) in group 2 (P < .001). Hemoglobin level after chest closure was 13.4 and 9.8 g/dL in groups 1 and 2, respectively (P < .001). Postoperative chest drainage (median) was 78 and 300 mL in groups 1 and 2, respectively (P = .003). Blood product requirement was zero and 3 units (median) in groups 1 and 2, respectively (P < .014). There was no significant difference in postoperative ventilation time or lengths of intensive care unit and hospital stays between the 2 groups. Mean follow-up was 15 months; all patients are in New York Heart Association I/II. Echocardiography showed that peak velocity across the pulmonary valve was 2.2 and 2.0 in groups 1 and 2, respectively (P = .46). No patient had a paravalvular leak or more than mild pulmonary regurgitation.
CONCLUSIONS: Off-pump pulmonary valve implantation is a good alternative for pulmonary valve replacement. The procedure reduces operating time, blood loss, and blood product requirement.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22713306     DOI: 10.1016/j.jtcvs.2012.05.036

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Use of oversized injectable valves in growing children for total repair of right ventricular outflow tract anomalies (preliminary results).

Authors:  Luca Deorsola; Pietro Angelo Abbruzzese
Journal:  Tex Heart Inst J       Date:  2014-08-01

Review 2.  Postoperative residua and sequelae in adults with repaired tetralogy of Fallot.

Authors:  Munetaka Masuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-04-26

Review 3.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

4.  Pulmonic regurgitation and management challenges in the adult with tetralogy of fallot.

Authors:  Emily Ruckdeschel; Joseph D Kay
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

Review 5.  Recent Development in Pulmonary Valve Replacement after Tetralogy of Fallot Repair: The Emergence of Hybrid Approaches.

Authors:  Tariq Suleiman; Clifford J Kavinsky; Clare Skerritt; Damien Kenny; Michael N Ilbawi; Massimo Caputo
Journal:  Front Surg       Date:  2015-06-02

6.  Hybrid Surgery Options for Complex Clinical Scenarios in Adult Patients with Congenital Heart Disease: Three Case Reports.

Authors:  Filippo Rapetto; Damien Kenny; Mark Turner; Andrew Parry; Serban Stoica; Orhan Uzun; Massimo Caputo
Journal:  Front Surg       Date:  2017-02-09

7.  'Off pump' self-expanding injectable tissue valves (IPVR) versus 'on pump' conventional tissue valves (PVR) for replacement of the pulmonary valve: trial protocol for a randomised controlled trial (InVITe trial).

Authors:  Rachael Heys; Gianni Angelini; Massimo Caputo; Lucy Culliford; Maria Pufulete; Barnaby C Reeves; Chris A Rogers; Serban Stoica; Andrew Parry
Journal:  BMJ Open       Date:  2019-04-02       Impact factor: 2.692

Review 8.  Recent advances in transcatheter management of pulmonary regurgitation after surgical repair of tetralogy of Fallot.

Authors:  Matthew I Jones; Shakeel A Qureshi
Journal:  F1000Res       Date:  2018-05-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.